OncoSec Medical Incorporated (ONCS)
Price:
0.28 USD
( + 0.07 USD)
Your position:
0 USD
ACTION PANEL
ABOUT
Check the
KEY TAKEAWAYS
ASK OUR AI ABOUT THE COMPANY (REGISTER FOR EARLY ACCESS)
(REGISTER FOR EARLY ACCESS) CHOOSE A PROMPT ABOVE TO ASK OUR AI ABOUT THE SPECIFIC INFORMATION
SIMILAR COMPANIES STI SCORE
Similar STI Score
BioNTech SE
VALUE SCORE:
6
2nd position
ADMA Biologics, Inc.
VALUE SCORE:
11
The best
Aurinia Pharmaceuticals Inc.
VALUE SCORE:
12
FUNDAMENTALS
FUNDAMENTALS
FUNDAMENTALS
FUNDAMENTALS PER SHARE
TECHNICAL
DIVIDEND
SIMILAR COMPANIES
No data to display
No data to display
No data to display
No data to display
No data to display
No data to display
No data to display
DESCRIPTION
OncoSec Medical Incorporated, a late-stage immuno-oncology company, focuses on designing, developing, commercializing intra-tumoral DNA-based therapeutics to stimulate and augment anti-tumor immune responses for the treatment of cancer. The company's lead product candidate is ImmunoPulse IL-12 that uses electroporation device to deliver a DNA-encoded interleukin-12 for reversing the immunosuppressive microenvironment in the treated tumor. It is also developing ImmunoPulse IL-12 with KEYTRUDA in patients with advanced melanoma that is in clinical trials collaboration and supply agreement (KEYNOTE-695) and metastatic triple negative breast cancer, which is in Phase II clinical trials (KEYNOTE-890); ImmunoPulse IL-12 and KEYTRUDA in patients with advanced or metastatic melanoma that has completed Phase II clinical trials; and ImmunoPulse IL-12 monotherapy in patients with metastatic melanoma, which has completed the Phase II clinical trials. In addition, the company is developing monotherapy biomarker study in patients with advanced or metastatic TNBC that has completed the Phase II clinical trials; and technology to treat liver, lung, bladder, pancreatic, and other visceral lesions. OncoSec Medical Incorporated has clinical trial collaborations with Merck & Co., Inc. and its subsidiary in connection with the KEYNOTE-695 and KEYNOTE-890 studies; a research collaboration with Duke University's Center for Applied Therapeutics to evaluate TAVO in combination or sequenced with a HER2-plasmid vaccine; a research collaboration with Roswell Park Comprehensive Cancer Center to evaluate the use of Roswell Park's intravital microscopy and enhanced IL-12 DNA-plasmid; and collaboration with Providence Cancer Institute. The company was formerly known as NetVentory Solutions Inc. and changed its name to OncoSec Medical Incorporated in March 2011. The company was incorporated in 2008 and is headquartered in Pennington, New Jersey.
NEWS
Why Is OncoSec Medical (ONCS) Stock Up 100% Today?
investorplace.com
2023-06-23 08:04:28OncoSec Medical (NASDAQ: ONCS ) stock is taking off on Friday after the company received a delisting notice yesterday. According to a filing with the Securities and Exchange Commission (SEC), the company has received a delisting notice from the Nasdaq Exchange.
Why Is OncoSec Medical (ONCS) Stock Down 48% Today?
investorplace.com
2023-06-15 09:01:57OncoSec Medical (NASDAQ: ONCS ) stock is falling hard on Thursday after the clinical-stage biotechnology company filed for bankruptcy. According to a filing with the Securities and Exchange Commission (SEC), OncoSec Medical is filing for bankruptcy after considering strategic alternatives.
3 Top Penny Stocks To Watch After Big News This Week
pennystocks.com
2023-05-16 13:59:00Hot penny stocks with big news this week. The post 3 Top Penny Stocks To Watch After Big News This Week appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.
Avoid Common Penny Stocks Trading Mistakes With These Tips
pennystocks.com
2023-03-03 06:00:00Use these tips for avoiding common penny stocks The post Avoid Common Penny Stocks Trading Mistakes With These Tips appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.
ONCS Stock: Over 120% Surge Explantion
pulse2.com
2023-03-01 10:00:04The stock price of OncoSec Medical Inc (NASDAQ: ONCS) skyrocketed over 120% intraday today. This is why.
Why is OncoSec Medical (ONCS) Stock Up 91% Today?
investorplace.com
2023-03-01 08:05:50OncoSec Medical (NASDAQ: ONCS ) stock is rising higher on Wednesday after the company withdrew a public stock offering. According to the company, it no longer wants to move forward with the offering.
Why Is OncoSec Medical (ONCS) Stock Down 25% Today?
investorplace.com
2023-02-02 08:47:53OncoSec Medical (NASDAQ: ONCS ) stock is falling on Thursday after the company revealed details of a stock offering. The biggest news from the company's prospectus is warrants of its stock having an exercise price of $2.02 per share.
Top 5 most-shorted stocks as of December 2022
finbold.com
2022-12-12 06:52:56More investors are interested in shorting and learning how they might benefit from a short squeeze as a result of the Reddit-fueled short squeeze on stocks like GameStop (NYSE: GME) and AMC Theaters (NYSE: AMC).
ONCS Stock Alert: What to Know About OncoSec Medical as It Drops Today
investorplace.com
2022-11-22 11:35:06Low-float stocks can do strange and unexpected things sometimes. That's as valid an explanation as any for the unusual price movement in OncoSec Medical (NASDAQ: ONCS ) stock today.
OncoSec Announces Pipeline Prioritization and Workforce Reduction
headlinesoftoday.com
2022-10-04 17:23:00PENNINGTON, N.J. and SAN DIEGO, Oct. 4, 2022 /PRNewswire/ — OncoSec Medical Incorporated (NASDAQ: ONCS) (the “Company” or “OncoSec”), a clinical-stage biotechnology company focused on developing intratumoral immunotherapies to stimulate the patient’s own immune system to target and eradicate cancer, today announced a corporate restructuring intended to prioritize development of its lead clinical candidate TAVO™ […]...
5 Top Penny Stocks Analysts Say To Buy With 119%-430% Price Targets
pennystocks.com
2021-10-15 12:02:575 Penny Stocks To Buy According To Analysts The post 5 Top Penny Stocks Analysts Say To Buy With 119%-430% Price Targets appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.
OncoSec to Participate in Fireside Chat at BTIG Virtual Biotechnology Conference
prnewswire.com
2021-07-26 08:30:00PENNINGTON, N.J. and SAN DIEGO, July 26, 2021 /PRNewswire/ -- OncoSec Medical Incorporated (NASDAQ:ONCS) (the "Company" or "OncoSec") today announced that Interim CEO and Chief Operating Officer, Brian Leuthner, and Senior Vice President, Chief Clinical Development Officer, Sandra Aung, Ph.D.
Top Penny Stocks to for Your Buy List Right Now? Here's 9 to Watch
pennystocks.com
2021-07-07 17:17:45Are these top penny stocks on your watchlist right now? The post Top Penny Stocks to for Your Buy List Right Now?
OncoSec Medical Stock Increases Over 25% Pre-Market: Why It Happened
pulse2.com
2021-07-07 07:17:07The stock price of OncoSec Medical Incorporated (NASDAQ:ONCS) increased by over 25% pre-market. This is why it happened.
OncoSec Enters into a Collaboration Agreement with Merck for a Pivotal Global Phase 3 Study, KEYNOTE-C87, of TAVO™ Combined with KEYTRUDA® for Late-Stage Metastatic Melanoma
prnewswire.com
2021-07-06 16:01:00PENNINGTON, N.J. and SAN DIEGO, July 6, 2021 /PRNewswire/ -- OncoSec Medical Incorporated (NASDAQ:ONCS) (the "Company" or "OncoSec") today announced it has entered into a Clinical Trial Collaboration and Supply Agreement ("Agreement") with Merck (known as MSD outside the United States and Canada) to evaluate the combination of OncoSec's DNA-plasmid interleukin-12 (IL-12) TAVO™ (tavokinogene telseplasmid) with Merck's anti-PD-1 therapy, KEYTRUDA® (pembrolizumab), in a global Phase 3 randomized clinical trial, KEYNOTE-C87.
OncoSec Appoints Brian Leuthner as Interim Chief Executive Officer
prnewswire.com
2021-06-24 16:30:00PENNINGTON, N.J. and SAN DIEGO, June 24, 2021 /PRNewswire/ -- OncoSec Medical Incorporated (NASDAQ:ONCS) (the "Company" or "OncoSec") today announced that Daniel O'Connor has resigned and that Brian Leuthner, formerly Chief Operating Officer, has been appointed Interim Chief Executive Officer, effective June 25, 2021.
No data to display
Why Is OncoSec Medical (ONCS) Stock Up 100% Today?
investorplace.com
2023-06-23 08:04:28OncoSec Medical (NASDAQ: ONCS ) stock is taking off on Friday after the company received a delisting notice yesterday. According to a filing with the Securities and Exchange Commission (SEC), the company has received a delisting notice from the Nasdaq Exchange.
Why Is OncoSec Medical (ONCS) Stock Down 48% Today?
investorplace.com
2023-06-15 09:01:57OncoSec Medical (NASDAQ: ONCS ) stock is falling hard on Thursday after the clinical-stage biotechnology company filed for bankruptcy. According to a filing with the Securities and Exchange Commission (SEC), OncoSec Medical is filing for bankruptcy after considering strategic alternatives.
3 Top Penny Stocks To Watch After Big News This Week
pennystocks.com
2023-05-16 13:59:00Hot penny stocks with big news this week. The post 3 Top Penny Stocks To Watch After Big News This Week appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.
Avoid Common Penny Stocks Trading Mistakes With These Tips
pennystocks.com
2023-03-03 06:00:00Use these tips for avoiding common penny stocks The post Avoid Common Penny Stocks Trading Mistakes With These Tips appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.
ONCS Stock: Over 120% Surge Explantion
pulse2.com
2023-03-01 10:00:04The stock price of OncoSec Medical Inc (NASDAQ: ONCS) skyrocketed over 120% intraday today. This is why.
Why is OncoSec Medical (ONCS) Stock Up 91% Today?
investorplace.com
2023-03-01 08:05:50OncoSec Medical (NASDAQ: ONCS ) stock is rising higher on Wednesday after the company withdrew a public stock offering. According to the company, it no longer wants to move forward with the offering.
Why Is OncoSec Medical (ONCS) Stock Down 25% Today?
investorplace.com
2023-02-02 08:47:53OncoSec Medical (NASDAQ: ONCS ) stock is falling on Thursday after the company revealed details of a stock offering. The biggest news from the company's prospectus is warrants of its stock having an exercise price of $2.02 per share.
Top 5 most-shorted stocks as of December 2022
finbold.com
2022-12-12 06:52:56More investors are interested in shorting and learning how they might benefit from a short squeeze as a result of the Reddit-fueled short squeeze on stocks like GameStop (NYSE: GME) and AMC Theaters (NYSE: AMC).
ONCS Stock Alert: What to Know About OncoSec Medical as It Drops Today
investorplace.com
2022-11-22 11:35:06Low-float stocks can do strange and unexpected things sometimes. That's as valid an explanation as any for the unusual price movement in OncoSec Medical (NASDAQ: ONCS ) stock today.
OncoSec Announces Pipeline Prioritization and Workforce Reduction
headlinesoftoday.com
2022-10-04 17:23:00PENNINGTON, N.J. and SAN DIEGO, Oct. 4, 2022 /PRNewswire/ — OncoSec Medical Incorporated (NASDAQ: ONCS) (the “Company” or “OncoSec”), a clinical-stage biotechnology company focused on developing intratumoral immunotherapies to stimulate the patient’s own immune system to target and eradicate cancer, today announced a corporate restructuring intended to prioritize development of its lead clinical candidate TAVO™ […]...
5 Top Penny Stocks Analysts Say To Buy With 119%-430% Price Targets
pennystocks.com
2021-10-15 12:02:575 Penny Stocks To Buy According To Analysts The post 5 Top Penny Stocks Analysts Say To Buy With 119%-430% Price Targets appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.
OncoSec to Participate in Fireside Chat at BTIG Virtual Biotechnology Conference
prnewswire.com
2021-07-26 08:30:00PENNINGTON, N.J. and SAN DIEGO, July 26, 2021 /PRNewswire/ -- OncoSec Medical Incorporated (NASDAQ:ONCS) (the "Company" or "OncoSec") today announced that Interim CEO and Chief Operating Officer, Brian Leuthner, and Senior Vice President, Chief Clinical Development Officer, Sandra Aung, Ph.D.
Top Penny Stocks to for Your Buy List Right Now? Here's 9 to Watch
pennystocks.com
2021-07-07 17:17:45Are these top penny stocks on your watchlist right now? The post Top Penny Stocks to for Your Buy List Right Now?
OncoSec Medical Stock Increases Over 25% Pre-Market: Why It Happened
pulse2.com
2021-07-07 07:17:07The stock price of OncoSec Medical Incorporated (NASDAQ:ONCS) increased by over 25% pre-market. This is why it happened.
OncoSec Enters into a Collaboration Agreement with Merck for a Pivotal Global Phase 3 Study, KEYNOTE-C87, of TAVO™ Combined with KEYTRUDA® for Late-Stage Metastatic Melanoma
prnewswire.com
2021-07-06 16:01:00PENNINGTON, N.J. and SAN DIEGO, July 6, 2021 /PRNewswire/ -- OncoSec Medical Incorporated (NASDAQ:ONCS) (the "Company" or "OncoSec") today announced it has entered into a Clinical Trial Collaboration and Supply Agreement ("Agreement") with Merck (known as MSD outside the United States and Canada) to evaluate the combination of OncoSec's DNA-plasmid interleukin-12 (IL-12) TAVO™ (tavokinogene telseplasmid) with Merck's anti-PD-1 therapy, KEYTRUDA® (pembrolizumab), in a global Phase 3 randomized clinical trial, KEYNOTE-C87.
OncoSec Appoints Brian Leuthner as Interim Chief Executive Officer
prnewswire.com
2021-06-24 16:30:00PENNINGTON, N.J. and SAN DIEGO, June 24, 2021 /PRNewswire/ -- OncoSec Medical Incorporated (NASDAQ:ONCS) (the "Company" or "OncoSec") today announced that Daniel O'Connor has resigned and that Brian Leuthner, formerly Chief Operating Officer, has been appointed Interim Chief Executive Officer, effective June 25, 2021.